Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
IBM stock popped as Q4 earnings and revenue topped Wall Street estimates while 2025 free cash flow guidance came in above expectations.